FLRY3.SA
FLRY3.SA
BRFLRYACNOR5
FLEURY ON NM
Loading chart...

Company Profile

Fleury S.A., together with its subsidiaries, engages in the provision of diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides medical services in the areas of diagnostics, laboratory support, infusions, clinical analyses, health management, healthcare, assistance medicine, orthopedics, ophthalmology, toxicological tests, fertility, infusions, and others. In addition, it operates a health platform, immunobiological drug infusion center, and ophthalmology service centers. Fleury S.A. was founded in 1926 and is headquartered in São Paulo, Brazil.

Related stocks

6127.HK
6127.HK • China
JOINN
31.32 HKD
2.99B USD 1Y +45%
300676.SZ
300676.SZ • China
BGI GENOMICS
45.47 CNY
2.85B USD 1Y -9.3%
CDNA
CDNA • United States
CareDx, Inc.
63.67 USD
3.29B USD 1Y +320.6%
SAILIFE.NS
SAILIFE.NS • India
SAI LIFE SCIENCES LIMITED
1,487.9 INR
3.27B USD 1Y +74.7%
LALPATHLAB.NS
LALPATHLAB.NS • India
DR. LAL PATH LABS LTD.
1,933.6 INR
3.34B USD 1Y +23.3%
VCYT
VCYT • United States
Veracyte, Inc.
45.23 USD
3.64B USD 1Y +24.2%
DIA.MI
DIA.MI • Italy
DIASORIN
77.42 EUR
4.27B USD 1Y -4.7%
ADPT
ADPT • United States
Adaptive Biotechnologies Corpor
26.49 USD
4.23B USD 1Y +67.8%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
31.7% p.a.
Max Drawdown (5Y)
-47.4%
Sharpe Ratio (5Y)
0.13
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (31.7% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -66.1% in the extended horizon.
ende